The effect of killer cell immunoglobulin-like receptor genotype on outcome of hematopoietic stem cell transplantation from matched sibling

Locatelli, 2013, Cellular and molecular basis of haploidentical hematopoietic stem cell transplantation in the successful treatment of high-risk leukemias: role of alloreactive NK cells, Front. Immunol., 4, 1 Ruggeri, 2002, Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants, Science, 295, 2097, 10.1126/science.1068440 Hsu, 2005, Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes, Blood, 105, 4878, 10.1182/blood-2004-12-4825 Foley, 2014, The biology Of NK cells and their receptors affects clinical outcomes after hematopoietic Cell transplantation (HCT), Immunol. Rev., 258, 45, 10.1111/imr.12157 Cooley, 2010, Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia, Blood, 116, 2411, 10.1182/blood-2010-05-283051 Clausen, 2007, Impact of natural killer cell dose and donor killer-cell immunoglobulin-like receptor (KIR) genotype on outcome following human leucocyte antigen-identical haematopoietic stem cell transplantation, Clin. Exp. Immunol., 148, 520, 10.1111/j.1365-2249.2007.03360.x Kanga, 2012, Role of killer immunoglobulin-like receptor-ligand interactions in human leukocyte antigen-matched sibling hematopoietic stem cell transplantation, Transplant. Proc., 44, 919, 10.1016/j.transproceed.2012.03.036 Miller, 1988, A simple salting out procedure for extracting DNA from human nucleated cells, Nucl. Acids Res., 16, 1215, 10.1093/nar/16.3.1215 Gonzalez-Galarza, 2015, Allele frequency net 2015 update: new features for HLA epitopes, KIR and disease and HLA adverse drug reaction associations, Nucl. Acid Res., 28, D784, 10.1093/nar/gku1166 Middleton, 2007, No association of KIR genes with Behcets disease, Tissue Antigens, 70, 435, 10.1111/j.1399-0039.2007.00929.x Osman, 2014, Characterization of human killer immunoglobulin-like receptors (KIRs) among healthy Saudis, Human Immunol., 75, 536, 10.1016/j.humimm.2014.02.023 Mahfouz, 2006, Distribution of killer cell immunoglobulin-like receptors genotypes in the Lebanese population, Tissue Antigens, 68, 66, 10.1111/j.1399-0039.2006.00605.x Hollenbach, 2010, Report from the killer immunoglobulin-like receptor (KIR) anthropology component of the 15th International Histocompatibility Workshop: worldwide variation in the KIR loci and further evidence for the co-evolution of KIR and HLA, Tissue Antigens, 76, 9 Hiby, 2010, Distribution of killer cell immunoglobulin-like receptors (KIR) and their HLA-C ligands in two Iranian populations, Immunogenetics, 62, 65, 10.1007/s00251-009-0408-5 Momot, 2004, Association of killer cell immunoglobulin-like receptors with scleroderma, Arthritis Rheum., 50, 1561, 10.1002/art.20216 Prakash, 2013, Distribution of Killer cell immunoglobulin like receptor genes in end stage renal disease among North Indian population, Human Immunol., 74, 1339, 10.1016/j.humimm.2013.06.015 Arnaiz-Villena, 1995, HLA allele and haplotype frequencies in Algerians: relatedness to Spaniards and Basques, Human Immunol., 43, 259, 10.1016/0198-8859(95)00024-X Ayed, 2004, HLA class-I and HLA class-II phenotypic, gene and haplotypic frequencies in Tunisians by using molecular typing data, Tissue Antigens, 64, 520, 10.1111/j.1399-0039.2004.00313.x HLA 1997, p222-223 Editor: P.I. Teraski & D.W. Gjertson. Papassavas, 2000, MHC class I and class II phenotype, gene, and haplotype frequencies in Greeks using molecular typing data, Human Immunol., 61, 615, 10.1016/S0198-8859(00)00115-4 Mack, 2009, HLA-A,-B,-C, and-DRB1 allele and haplotype frequencies distinguish Eastern European Americans from the general European American population, Tissue Antigens, 73, 17, 10.1111/j.1399-0039.2008.01151.x Burek Kamenaric, 2017, The impact of KIR2DS4 gene on clinical outcome after hematopoietic stem cell transplantation, Hum. Immunol., 78, 95, 10.1016/j.humimm.2016.11.010 Wu, 2016, KIR2DS4 and its variant KIR1D are associated with acute graft-versus-host disease, cytomegalovirus, and overall survival after sibling-related HLA-matched transplantation in patients with donors with KIR gene haplotype A, Biol. Blood Marrow Transplant., 22, 220, 10.1016/j.bbmt.2015.10.004 Cooley, 2009, Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia, Blood, 113, 726, 10.1182/blood-2008-07-171926 Stringaris, 2010, Donor KIR Genes 2DL5A, 2DS1 and 3DS1 are associated with a reduced rate of leukemia relapse after HLA-identical sibling stem cell transplantation for acute myeloid leukemia but not other hematologic malignancies, Biol. Blood Marrow Transplant., 16, 1257, 10.1016/j.bbmt.2010.03.004 Verheyden, 2005, A defined donor activating natural killer cell receptor genotype protects against leukemic relapse after related HLA-identical hematopoietic stem cell transplantation, Leukemia, 19, 446, 10.1038/sj.leu.2403839 Impola, 2014, Donor haplotype B of NK KIR receptor reduces the relapse risk in HLA-identical sibling hematopoietic stem cell transplantation of AML patients, Front. Immunol., 5, 405, 10.3389/fimmu.2014.00405 Zhou, 2014, Donor selection for killer immunoglobulin-like receptors B haplotype of the centromeric motifs can improve the outcome after HLA-identical sibling hematopoietic stem cell transplantation, Biol. Blood Marrow Transplant., 20, 98, 10.1016/j.bbmt.2013.10.017 Miller, 2005, Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer, Blood, 105, 3051, 10.1182/blood-2004-07-2974 McQueen, 2007, Donor–recipient combinations of group A and B KIR haplotypes and HLA class I ligand affect the outcome of HLA-matched, sibling donor hematopoietic cell transplantation, Human Immunol., 68, 309, 10.1016/j.humimm.2007.01.019 Cook, 2004, The impact of donor KIR and patient HLA-C genotypes on outcome following HLA-identical sibling hematopoietic stem cell transplantation for myeloid leukemia, Blood, 103, 1521, 10.1182/blood-2003-02-0438 Fischer, 2007, Relevance of C1 and C2 epitopes for hemopoietic stem cell transplantation: role for sequential acquisition of HLA-C-specific inhibitory killer Ig-like receptor, J. Immunol., 178, 3918, 10.4049/jimmunol.178.6.3918 Venstrom, 2012, HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1, N. Engl. J. Med., 367, 805, 10.1056/NEJMoa1200503 Sobecks, 2015, Impact of KIR and HLA genotypes on outcomes after reduced-intensity conditioning hematopoietic cell transplantation, Biol. Blood Marrow Transplant., 21, 1589, 10.1016/j.bbmt.2015.05.002 Sekine, 2016, Specific combinations of donor and recipient KIR-HLA genotypes predict for large differences in outcome after cord blood transplantation, Blood, 128, 10.1182/blood-2016-03-706317 Neuchel, 2017, Impact of donor activating KIR genes on HSCT outcome in C1-ligand negative myeloid disease patients transplanted with unrelated donors-a retrospective study, PLoS One, 12, 10.1371/journal.pone.0169512 Pfeiffer, 2010, Reconstitution of natural killer cell receptors influences natural killer activity and relapse rate after haploidentical transplantation of T-and B-cell depleted grafts in children, Haematologica, 95, 1381, 10.3324/haematol.2009.021121 Shimoni, 2017, Missing HLA C group 1 ligand in patients with AML and MDS is associated with reduced risk of relapse and better survival after allogeneic stem cell transplantation with fludarabine and treosulfan reduced toxicity conditioning, Am. J. Hematol., 10.1002/ajh.24827 Cardozo, 2016, Synergistic effect of KIR ligands missing and cytomegalovirus reactivation in improving outcomes of haematopoietic stem cell transplantation from HLA-matched sibling donor for treatment of myeloid malignancies, Hum. Immunol., 77, 861, 10.1016/j.humimm.2016.07.003 Beziat, 2009, Fully functional NK cells after unrelated cord blood transplantation, Leukemia, 23, 721, 10.1038/leu.2008.343 Cook, 2006, Donor KIR genotype has a major influence on the rate of cytomegalovirus reactivation following T-cell replete stem cell transplantation, Blood, 107, 1230, 10.1182/blood-2005-03-1039 Zaia, 2009, The effect of single and combined activating killer immunoglobulin-like receptor genotypes on cytomegalovirus infection and immunity after hematopoietic cell transplantation, Biol. Blood Marrow Transplant., 15, 315, 10.1016/j.bbmt.2008.11.030 Sobecks, 2011, Cytomegalovirus reactivation after matched sibling donor reduced-intensity conditioning allogeneic hematopoietic stem cell transplant correlates with donor killer immunoglobulin-like receptor genotype, Exp. Clin. Transplant., 9, 7 Tomblyn, 2009, Myeloablative hematopoietic cell transplantation for acute lymphoblastic leukemia: analysis of graft sources and long-term outcome, J. Clin. Oncol., 27, 3634, 10.1200/JCO.2008.20.2960 Giebel, 2009, Activating killer immunoglobulin-like receptor incompatibilities enhance graft-versus-host disease and affect survival after allogeneic hematopoietic stem cell transplantation, Eur. J. Haematol., 83, 343, 10.1111/j.1600-0609.2009.01280.x Gagne, 2002, Relevance of KIR gene polymorphisms in bone marrow transplantation outcome, Human Immunol., 63, 271, 10.1016/S0198-8859(02)00373-7 Kim, 2007, The activating killer cell immunoglobulin-like receptors as important determinants of acute graft-versus host disease in hematopoietic stem cell transplantation for acute myelogenous leukemia, Transplantation, 84, 1082, 10.1097/01.tp.0000285918.72930.35 Cooley, 2005, KIR reconstitution is altered by T cells in the graft and correlates with clinical outcomes after unrelated donor transplantation, Blood, 106, 4370, 10.1182/blood-2005-04-1644 Sun, 2007, Detrimental effect of natural killer cell alloreactivity in T-replete hematopoietic cell transplantation (HCT) for leukemia patients, Biol. Blood Marrow Transplant., 13, 197, 10.1016/j.bbmt.2006.09.009 Vivier, 2008, Functions of natural killer cells, Nature Immunol., 9, 503, 10.1038/ni1582 Brahmi, 2001, NK cells recover early and mediate cytotoxicity via perforin/granzyme and Fas/FasL pathways in umbilical cord blood recipients, Hum. Immunol., 62, 782, 10.1016/S0198-8859(01)00275-0 Tiberghien, 1990, Anti-asialo GM1 antiserum treatment of lethally irradiated recipients before bone marrow transplantation: evidence that recipient natural killer depletion enhances survival, engraftment, and hematopoietic recovery, Blood, 76, 1419, 10.1182/blood.V76.7.1419.1419 Sobecks, 2007, Survival of AML patients receiving HLA-matched sibling donor allogeneic bone marrow transplantation correlates with HLA-Cw ligand groups for killer immunoglobulin-like receptors, Bone Marrow Transplant., 39, 417, 10.1038/sj.bmt.1705609 Soiffer, 2011, Impact of immune modulation with anti–T-cell antibodies on the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies, Blood, 117, 6963, 10.1182/blood-2011-01-332007